摘要
While The World Health Organization (WHO) has announced that COVID-19 is no longer a public health emergency of international concern(PHEIC), the risk of reinfection and new emerging variants still makes it crucial to study and work towards the prevention of COVID-19. Stem cell and stem cell-like derivatives have shown some promising results in clinical trials and preclinical studies as an alternative treatment option for the pulmonary illnesses caused by the COVID-19 and can be used as a potential vaccine. In this review, we will systematically summarize the pathophysiological process and potential mechanisms underlying stem cell-based therapy in COVID-19, and the registered COVID-19 clinical trials, and engineered extracellular vesicle as a potential vaccine for preventing COVID-19.
学科与关键词
- Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDSXu, Zhiheng; Huang, Yongbo; Zhou, Jianmeng; Deng, Xiumei; He, Weiqun; Liu, Xiaoqing; Li, Yimin; Zhong, Nanshan*; Sang, Ling*Frontiers in Immunology, 2021, 12: 738697.被引 13
- Mesenchymal stem cell treatment for COVID-19Xu, Ruonan*; Feng, Zhiqian; Wang, Fu-Sheng*EBioMedicine, 2022, 77: 103920.被引 32
- Immune-Cell-Based Therapy for COVID-19: Current StatusWang, Yiyuan; Liang, Qinghe; Chen, Fengsheng; Zheng, Jiehuang; Chen, Yan; Chen, Ziye; Li, Ruopeng; Li, Xiaojuan*Viruses-Basel, 2023, 15(11): 2148.
